UNITED THERAPEUTICS earnings

Next report

Expected around early November, going by its own filing history. The company has not announced a date yet. Its matching report came Oct 29, 2025 and Oct 30, 2024, during the session.

Who else reports that week: the earnings calendar.

Last report: Aug 5, 2026, 10:33 ET (during the session). The filing on SEC EDGAR ↗

Across the last 4 reports we hold closes for, the first close moved a median 6.96% either way. Up 4 of 4.

Moves are only shown for reports where we hold closing prices.

1. Aug 5, 202610:33 ET · during the session8-K ↗+0.06%1DRevenue $783.3M−1.9% y/yEPS $7.27quarter to Jun 30, 2026
2. May 6, 202610:31 ET · during the session8-K ↗+4.29%1DRevenue $781.5M−1.6% y/yEPS $5.82quarter to Mar 31, 2026
3. Feb 25, 202611:32 ET · during the session8-K ↗+13.03%1DRevenue $790.2M+7.4% y/yquarter to Dec 31, 2025
4. Oct 29, 202510:34 ET · during the session8-K ↗+9.63%1DRevenue $799.5M+6.8% y/yEPS $7.16quarter to Sep 30, 2025
5. Before Sep 2, 2025 we don't hold closing prices, so these reports show the date and what was filed, without a move.
6. Jul 30, 202510:36 ET · during the session8-K ↗Revenue $798.6M+11.7% y/yEPS $6.41quarter to Jun 30, 2025
7. Apr 30, 202510:33 ET · during the session8-K ↗Revenue $794.4M+17.2% y/yEPS $6.63quarter to Mar 31, 2025
8. Feb 26, 202511:35 ET · during the session8-K ↗Revenue $735.9M+19.7% y/yquarter to Dec 31, 2024
9. Oct 30, 202410:34 ET · during the session8-K ↗Revenue $748.9M+22.9% y/yEPS $6.39quarter to Sep 30, 2024
10. Jul 31, 202410:33 ET · during the session8-K ↗Revenue $714.9M+19.8% y/yEPS $5.85quarter to Jun 30, 2024
11. May 1, 202410:34 ET · during the session8-K ↗Revenue $677.7M+33.7% y/yEPS $6.17quarter to Mar 31, 2024
12. Feb 21, 202411:05 ET · during the session8-K ↗Revenue $614.7M+25.1% y/yquarter to Dec 31, 2023
13. Nov 1, 202310:05 ET · during the session8-K ↗Revenue $609.4M+18.1% y/yEPS $5.38quarter to Sep 30, 2023
14. Aug 2, 202310:05 ET · during the session8-K ↗Revenue $596.5M+27.8% y/yEPS $5.24quarter to Jun 30, 2023
15. May 3, 202310:06 ET · during the session8-K ↗Revenue $506.9M+9.7% y/yEPS $4.86quarter to Mar 31, 2023

Move = the first close after the release against the close before it. A release after 4pm ET is priced by the next session; one before 9:30am ET by that day’s. Times are when the SEC accepted the 8-K (Item 2.02), which follows the press release by minutes. Closes held from Sep 2, 2025; “no price data” means we don't hold the closes for that report. Prior-session closes only; not a forecast, not advice.